Summary

Its report, “The Future of the Neurology Devices Market to 2016 - Market Forecasts, Competitive Landscape and Pipeline Analysis” provides key data, information and analysis on the global neurology devices market, a key segment within the medical device industry. This medical device report provides market landscape, competitive landscape and market trends information on five neurology devices market categories - CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology and Radiosurgery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Its team of industry experts.

Scope

- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for five neurology devices market categories – Cerebro Spinal Fluid (CSF) Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology and Radiosurgery.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the neurology devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Boston Scientific, Cordis, St. Jude Medical, Cyberonics, ev3, Elekta, Accuray, B. Braun, and Codman & Shurtleff.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the neurology devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the neurology devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global neurology devices market and the factors shaping it.

Company Mentioned
Medtronic
Boston Scientific Corporation
St. Jude Medical
Cordis Corporation
ev3

1
1 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 GBI Research Guidance 8
3 Neurology Devices: Market Characterization 9
3.1 Global Neurology Devices Market, Revenue ($ billion), 2002 – 2009 9
3.2 Global Neurology Devices Market, Revenue Forecast ($ billion), 2009 – 2016 10
3.3 Global Neurology Devices Market, Key Trends 10
3.3.1 Technological Advances to be a Mainstay in the Neurology Devices Market 10
3.3.2 Neurology Devices Market is Increasingly Attracting Interest from Cardiovascular Device Companies 11
3.3.3 Remote Patient Monitoring is a Distinct Possibility in near Future 11
3.4 Neurology Devices, Market Dynamics 11
3.4.1 Market Drivers 11
3.4.2 Market Restraints 12
3.5 Global Neurology Devices Market, Key Company Share (%), 2008 14
4 Global Neurology Devices Market: Category Analysis and Forecasts 15
4.1 Neurostimulation Devices 15
4.2 Neurostimulation Devices Market, Global, Revenue ($m), 2002 – 2009 16
4.3 Neurostimulation Devices Market, Global, Revenue Forecast ($m), 2009 – 2016 17
4.4 Neurostimulation Devices: Market Dynamics 17
4.4.1 Market Drivers 17
4.4.2 Market Restraints 19
4.5 Neurostimulation Devices Market, Global, Company Shares (%), 2008 20
4.6 Interventional Neurology 20
4.7 Interventional Neurology Market, Global, Revenue ($m), 2002 – 2009 21
4.8 Interventional Neurology Market, Global, Revenue Forecast ($m), 2009 – 2016 22
4.9 Interventional Neurology: Market Dynamics 22
4.9.1 Market Drivers 22
4.9.2 Market Restraints 23
4.10 Interventional Neurology Market, Global, Company Shares (%), 2008 24
4.11 CSF Management 24
4.12 CSF Management Market, Global, Revenue ($m), 2002 – 2009 25
4.13 Global CSF Management Market, Revenue Forecasts ($m), 2009 – 2016 26
4.14 CSF Management: Market Dynamics 26
4.14.1 Market Driver: Hydrocephalus Prevalence to Drive the Market in the Future 26
4.14.2 Market Restraint: Lack of Accurate Diagnosis is Slowing the Market Growth 27
4.15 Global CSF Management Market, Global, Company Shares (%), 2008 27
4.16 Neurosurgical Products 27
4.17 Neurosurgical Products Market, Global, Revenue ($m), 2002 – 2009 28
4.18 Neurosurgical Products Market, Global, Revenue Forecast ($m), 2009 – 2016 29
4.19 Neurosurgical Products: Market Dynamics 29
4.19.1 Market Drivers 29
4.19.2 Market Restraints: Technical Difficulties in Performing the Procedure and Advent of Ventricular Shunts is Slowing the Market Growth 30
4.20 Global Neurosurgical Products Market, Key Company Shares (%), 2008 30
4.21 Radiosurgery 31
4.22 Global Radiosurgery Market, Global, Revenue ($m), 2002 – 2009 31
4.23 Global Radiosurgery Market, Revenue Forecasts ($m), 2009 – 2016 32
4.24 Radiosurgery: Market Dynamics 32
4.24.1 Market Drivers 32
4.24.2 Market Restraint: High Cost of Radiosurgery Systems is Slowing the Purchasing Decision of the Hospitals 33
4.25 Global Radiosurgery Market, Key Company Shares (%), 2008 33
5 Global Neurology Devices Market: Country Analysis and Forecasts 35
5.1 Neurology Devices Market: Cross-Country Analysis 35
5.2 Revenue, By Country, 2002 – 2009 36
5.2.1 The US Neurology Devices Market, Revenues ($m), 2002 – 2009 36
5.2.2 Canada Neurology Devices Market, Revenues ($m), 2002 – 2009 36
5.2.3 The UK Neurology Devices Market, Revenues ($m), 2002 – 2009 37
5.2.4 Germany Neurology Devices Market, Revenues ($m), 2002 – 2009 38
5.2.5 France Neurology Devices Market, Revenues ($m), 2002 – 2009 38
5.2.6 Italy Neurology Devices Market, Revenues ($m), 2002 – 2009 39
5.2.7 Spain Neurology Devices Market, Revenues ($m), 2002 – 2009 40
5.2.8 Japan Neurology Devices Market, Revenues ($m), 2002 – 2009 40
5.2.9 China Neurology Devices Market, Revenues ($m), 2002 – 2009 41
5.2.10 India Neurology Devices Market, Revenues ($m), 2002 – 2009 42
5.2.11 Australia Neurology Devices Market, Revenues ($m), 2002 – 2009 42
5.2.12 Brazil Neurology Devices Market, Revenues ($m), 2002 – 2009 43
5.3 Revenue Forecasts, By Country, 2009 – 2016 44
5.3.1 The US Neurology Devices Market, Revenues ($m), 2009 – 2016 44
5.3.2 Canada Neurology Devices Market, Revenues ($m), 2009 – 2016 44
5.3.3 The UK Neurology Devices Market, Revenues ($m), 2009 – 2016 45
5.3.4 Germany Neurology Devices Market, Revenues ($m), 2009 – 2016 46
5.3.5 France Neurology Devices Market, Revenues ($m), 2009 – 2016 46
5.3.6 Italy Neurology Devices Market, Revenues ($m), 2009 – 2016 47
5.3.7 Spain Neurology Devices Market, Revenues ($m), 2009 – 2016 48
5.3.8 Japan Neurology Devices Market, Revenues ($m), 2009 – 2016 48
5.3.9 China Neurology Devices Market, Revenues ($m), 2009 – 2016 49
5.3.10 India Neurology Devices Market, Revenues ($m), 2009 – 2016 50
5.3.11 Australia Neurology Devices Market, Revenues ($m), 2009 – 2016 50
5.3.12 Brazil Neurology Devices Market, Revenues ($m), 2009 – 2016 51
6 Global Neurology Devices Market: Competitive Assessment 52
6.1 Medtronic 52
6.2 Boston Scientific Corporation 53
6.3 St. Jude Medical 54
6.4 Cordis Corporation 55
6.5 ev3 55
7 Global Neurology Devices Market: Product Pipeline Analysis 57
7.1 Neurostimulation Devices 57
7.1.1 Boston Scientific Corporation: Bion Microstimulator System 58
7.1.2 NeuroPro Technologies: Deep Brain Stimulation 58
7.1.3 Brainsway: Deep TMS H System 58
7.1.4 Cyberonics: Direct Deep Brain Stimulation 58
7.1.5 Intelect Medical: Enspire DBS Therapy system for stroke 58
7.1.6 Intelect Medical: Enspire Deep Stimulation therapy system 58
7.1.7 St. Jude Medical: Libra Deep Brain Stimulation System 59
7.1.8 St. Jude Medical: Libra Deep Brain Stimulation System-depression 59
7.1.9 St. Jude Medical: Libra Deep Brain Stimulation System-essential tremor 59
7.1.10 St. Jude Medical: LibraXP Deep Brain Stimulation System 59
7.1.11 The Magstim Company Limited: Magstim Rapid 59
7.1.12 Cleveland Medical Devices: ParkinTune 60
7.1.13 Northstar Neuroscience: Renova-DT Cortical Stimulation System 60
7.1.14 Duke University: Spinal Cord Stimulator 60
7.1.15 DynaMed Systems: Traxon 60
7.1.16 Cyberonics: 3T MRI Safe Lead 60
7.1.17 Cyberonics: Nerve Wrap 61
7.1.18 Cyberonics: Next Generation Programmer-VNS therapy 61
7.1.19 Cyberonics: Next Generation Wand-VNS therapy 61
7.1.20 Cyberonics: NXT HC-Pulse Generator 61
7.1.21 Cyberonics: NXT NP-Pulse Generator 61
7.1.22 Cyberonics: NXT SR-Pulse Generator 61
7.1.23 Boston Scientific Corporation: Precision Implantable neurostimulator 62
7.1.24 MICROTRANSPONDER: Wireless Vagus Nerve Stimulator 62
7.2 Interventional Neurology 63
7.2.1 Neurovasx: cPAX Aneurysm Treatment System 63
7.2.2 ev3: Pipeline Embolization Device 64
7.2.3 BioCure: GelCoil 64
7.2.4 Micrus Endovascular Corporation: Occlusion balloons 64
7.2.5 Micrus Endovascular Corporation: Cerecyte Microcoil 64
7.2.6 Micrus Endovascular Corporation: InterPaq Microcoil 64
7.2.7 Micrus Endovascular Corporation: MicruSphere Microcoil 64
7.2.8 Micrus Endovascular Corporation: UltiPaq Microcoil 65
7.2.9 Micrus Endovascular Corporation: Liquid embolic product 65
7.2.10 Valor Medical: Neucrylate 65
7.2.11 Surpass Medical Ltd: Brain Aneurysm Occluder 65
7.2.12 Micrus Endovascular Corporation: Flow diversion technology 65
7.2.13 W. L. Gore & Associates: GORE Embolic Filter 66
7.2.14 ev3: Solitaire FR Revascularization Device 66
7.3 CSF Management 66
7.3.1 NeuroDx Development LLC: ICP Check 66
7.3.2 Neuro Diagnostic Devices: Implantable ICP monitor 66
7.3.3 University of Cincinnati: Smart Sensor 67
7.3.4 University Hospital Zurich: SmartShunt 67
7.3.5 CSF Therapeutics: CSF Therapeutic device 67
7.3.6 NeuroSystems, LLC: Multimodality monitoring 67
7.3.7 Biosan Medical Ltd: Ventrite